Potency after permanent prostate brachytherapy for localized prostate cancer.
about
Health-related quality of life after prostate brachytherapy.Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.Management of complications of prostate cancer treatment.High-risk prostate cancer in the United States, 1990-2007Impact of androgen deprivation therapy on sexual functionNational practice patterns and time trends in androgen ablation for localized prostate cancer.Management of erectile dysfunction secondary to treatment for localized prostate cancer.Development of UK guidance on the management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer.Long-term complications of brachytherapy in local prostate cancer.Iodine seed prostate brachytherapy: an alternative first-line choice for early prostate cancer.Specific aspects of erectile function in urology/andrology.Prostate cancer treatment. The case for radical prostatectomyPast, present, and future: a 7-year update of Viagra (sildenafil citrate).Estimating the risk of long-term erectile, urinary and bowel symptoms resulting from prostate cancer treatment.Long-term results of interstitial brachytherapy (LDR-Brachytherapy) in the treatment of patients with prostate cancer.A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer.Erectile dysfunction following radiotherapy and brachytherapy for prostate cancer: pathophysiology, prevention and treatment.Minimally invasive surgical modalities in the management of localized prostate cancer.Sexual function and male cancer.Injectable polypeptide micelles that form radiation crosslinked hydrogels in situ for intratumoral radiotherapy.Current status of brachytherapy for prostate cancer.Hypoxia response element-driven cytosine deaminase/5-fluorocytosine gene therapy system: a highly effective approach to overcome the dynamics of tumour hypoxia and enhance the radiosensitivity of prostate cancer cells in vitro.Erectile function following brachytherapy, external beam radiotherapy, or radical prostatectomy in prostate cancer patients.Management of post-radiation therapy complications among prostate cancer patients: A case series.Early intervention with phosphodiesterase-5 inhibitors after prostate brachytherapy improves subsequent erectile function.Erectile function after brachytherapy with external beam radiation for prostate cancer.Neoadjuvant hormonal therapy and external-beam radiotherapy versus external-beam irradiation alone for prostate cancer. A quality-of-life analysis.Defining sexual outcomes after treatment for localized prostate carcinoma.Prospective evaluation of a specific technique of sexual function preservation in external beam radiotherapy for prostate cancer.Penile Rehabilitation Strategies Among Prostate Cancer Survivors.Five-year potency preservation after iodine-125 prostate brachytherapy.
P2860
Q30434306-655C3778-01C4-45D1-BD1A-C197D3CEB1AEQ30435131-8D4837C4-68B2-4DB2-847F-20B2F41868BDQ33978360-4FD99644-93E3-4BB9-A994-F1DE4D8EF01BQ34168382-1C6564F5-F0DD-400D-8DBB-10B1E18E899BQ34245932-05401C20-CCE2-4B72-B7A0-1CA388051208Q34363769-2FF8758E-1280-4D20-86B6-A330499E1145Q34504227-68D7889C-D83E-408B-8F09-D6A404F64D25Q35022939-F2545FDF-38FB-4C17-BAE2-BC9BA7EB32B4Q35583210-BB354C74-9EED-4E27-A40F-2C8A740CEE1FQ35797101-45EE4005-EA57-4B01-8A98-C18E97A1A255Q35924328-3C671053-70B9-4409-9108-A76036D43F14Q36014301-B50EDE9B-B161-40C4-86F8-11482025F4A3Q36144234-39C04BD1-29CA-4C10-994E-8673E0EE9E80Q36364403-A774E5C1-E9BD-480D-B7B0-C2E6FE3997B3Q36463101-AA781F49-3BCC-40AF-81B1-8DFE16A0D0B8Q36740528-B50610E1-6CE3-4D6F-86E4-66916B6C7524Q36981272-636D624C-8B6E-44F6-BCA2-0AA69E28446AQ37183470-5BE1B414-B103-4F39-8E82-F921057F4AA1Q38713723-C618A4A4-6E01-42E8-A24E-CBECE263BD76Q38790048-0855A306-166E-4239-9CD0-457325D8B040Q39513542-73DBB29A-836E-472D-B374-C0030F542207Q39909671-AD9571E4-0334-4F2B-9BA7-C76D29D1118DQ40162552-B695A98D-F9D4-4B4C-9524-B6408744455EQ41711416-4ECF042B-E1E3-46D7-AD9B-0400EC61410BQ43061489-EFF20A13-91A0-4EC9-8021-B8A31BCA300EQ44995229-BB5E60FE-36D1-402B-9617-94DD449E782FQ46160400-EEEEB5A9-2AAC-400A-9504-C1CE512E4BE8Q47567812-A3983BBE-57F9-452D-A87D-38F9B13E41C3Q50518703-E95B1DA6-8D1F-46C4-BDC7-09D1A4E3E56AQ53757607-69178449-86B4-4AC2-A020-6B5B2239C9C5Q54678346-F0B7BEE2-D72D-43F1-9BB5-63A5D74AD954
P2860
Potency after permanent prostate brachytherapy for localized prostate cancer.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Potency after permanent prostate brachytherapy for localized prostate cancer.
@en
Potency after permanent prostate brachytherapy for localized prostate cancer.
@nl
type
label
Potency after permanent prostate brachytherapy for localized prostate cancer.
@en
Potency after permanent prostate brachytherapy for localized prostate cancer.
@nl
prefLabel
Potency after permanent prostate brachytherapy for localized prostate cancer.
@en
Potency after permanent prostate brachytherapy for localized prostate cancer.
@nl
P2093
P1476
Potency after permanent prostate brachytherapy for localized prostate cancer.
@en
P2093
P304
P356
10.1016/S0360-3016(01)01578-4
P407
P577
2001-08-01T00:00:00Z